Apple vs. Masimo: A Case Study in Patent Infringement

The Big Bite: Apple’s Smartwatch Sales Halted in Patent Dispute

Smartwatches are booming, blending technology with everyday convenience. But even giants like Apple can face challenges when it comes to intellectual property (IP). Let’s delve into the recent patent infringement case between Apple and medical technology company Masimo.

What is Patent Infringement?

A patent grants the owner exclusive rights to an invention for a limited time. If someone uses, makes, or sells the invention without permission, it’s patent infringement. Patent infringement lawsuits can have serious consequences, including:

  • Sales bans (as Apple experienced)
  • Financial damages
  • Reputational harm

The Case: Blood Oxygen Tech Under Scrutiny

Masimo, a leader in medical monitoring technology, claims Apple’s Series 9 and Ultra 2 smartwatches infringe on their patents for light-based pulse oximetry technology. This technology measures blood oxygen levels using light.

Masimo filed a complaint with the US International Trade Commission (ITC), leading to a temporary halt on US sales of the accused Apple Watch models. While Apple successfully appealed for a temporary resumption of sales, the case is ongoing.

Lessons Learned

This case highlights several crucial points:

  • IP Matters: Strong IP protection is essential for businesses of all sizes.
  • David vs. Goliath: Even large companies can be vulnerable to patent infringement claims.
  • The Price of Infringement: Patent infringement can be costly and disruptive.

Protect Your Innovations

Here are some tips to safeguard your intellectual property:

  • Conduct thorough patent searches before developing new products.
  • Consult with an IP attorney to build a comprehensive strategy.
  • Stay informed about IP trends in your industry.

Stay Tuned

The Apple vs. Masimo case is a reminder of the importance of IP. We’ll continue to monitor developments and share insights on protecting your innovations.

Do you have questions about patent infringement? Ask us.


By: Prem Shah and Sanjaykumar Patel

Leave a Reply